Cargando…

Patient-reported outcome measures in definitive chemoradiation for non-small cell lung cancer

Detalles Bibliográficos
Autores principales:	Voong, Khinh Ranh, Feliciano, Josephine L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082294/ https://www.ncbi.nlm.nih.gov/pubmed/32206547 http://dx.doi.org/10.21037/tlcr.2019.10.06

Ejemplares similares

Hospitalization and definitive radiotherapy in lung cancer: incidence, risk factors and survival impact
por: Hazell, Sarah Z., et al.
Publicado: (2020)

Case Report: Hematologic Recovery Following Stereotactic Ablative Radiotherapy in a Patient With Early-Stage Non-Small Cell Lung Cancer and Paraneoplastic Myelofibrosis
por: Sloan, Lindsey, et al.
Publicado: (2022)

Implementation of patient reported outcomes in definitive chemoradiation for non-small cell lung cancer
por: Vogel, Jennifer, et al.
Publicado: (2020)

Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (≥60 Gy) and factors influencing consideration for surgery in stage III non-small cell lung cancer
por: Vyfhuis, Melissa A.L., et al.
Publicado: (2017)

DAART: a deep learning platform for deeply accelerated adaptive radiation therapy for lung cancer
por: Hooshangnejad, Hamed, et al.
Publicado: (2023)

Should salvage surgery be considered for local recurrence after definitive chemoradiation in locally advanced non-small cell lung cancer?
por: Schreiner, Waldemar, et al.
Publicado: (2016)

Predictors of Pneumonitis in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Definitive Chemoradiation Followed by Consolidative Durvalumab
por: Diamond, Brett H., et al.
Publicado: (2022)

The Impact of Serum Glucose, Anti-Diabetic Agents, and Statin Usage in Non-small Cell Lung Cancer Patients Treated With Definitive Chemoradiation
por: Iarrobino, Nick A., et al.
Publicado: (2018)

Outcomes by time to definitive chemoradiation treatment for patients with muscle-invasive bladder cancer
por: Kotha, Nikhil V., et al.
Publicado: (2022)

Definitive chemoradiation in patients with inoperable oesophageal carcinoma
por: Crosby, T D L, et al.
Publicado: (2004)

Dietary Flaxseed in Non-Small Cell Lung Cancer Patients Receiving Chemoradiation
por: Berman, Abigail T, et al.
Publicado: (2013)

Definitive Chemoradiation Associated with Improved Survival Outcomes in Patients with Synchronous Oligometastatic Esophageal Cancer
por: Matoska, Thomas, et al.
Publicado: (2023)

Multi-institutional analysis of aneuploidy and outcomes to chemoradiation and durvalumab in stage III non-small cell lung cancer
por: Alessi, Joao V, et al.
Publicado: (2023)

Four-Phase, Definitive Chemoradiation for a Real-World (Poor Risk and/or Elderly) Patient Population With Locally Advanced Non-small Cell Lung Cancer
por: Zhou, Yu M, et al.
Publicado: (2022)

Clinical complete responders to definite chemoradiation or radiation therapy for oesophageal cancer: predictors of outcome
por: Adenis, Antoine, et al.
Publicado: (2013)

Leukocytosis and neutrophilia predict outcome in locally advanced esophageal cancer treated with definitive chemoradiation
por: Schernberg, Antoine, et al.
Publicado: (2017)

Chemoradiation followed by adjuvant durvalumab in stage III non–small cell lung cancer: Real‐world comparison of treatment outcomes to historical controls treated with chemoradiation alone
por: Saad, Akram, et al.
Publicado: (2022)

Pretreatment Lung Function and Checkpoint Inhibitor Pneumonitis in NSCLC
por: Reuss, Joshua E., et al.
Publicado: (2021)

Clinical Responses and Prognostic Indicators of Concurrent Chemoradiation for Non-small Cell Lung Cancer
por: Lee, Dong-Soo, et al.
Publicado: (2011)

Comparison between concurrent and sequential chemoradiation for non-small cell lung cancer in vitro
por: SONG, SEO-YOUNG, et al.
Publicado: (2014)

Challenges in optimizing chemoradiation in locally advanced non small-cell lung cancers in India
por: Agrawal, Sushma
Publicado: (2013)

Radiologic response of chemotherapy alone versus radiation and chemotherapy in the treatment of locally‐advanced or advanced thymic epithelial tumors
por: Chu, Robert F., et al.
Publicado: (2020)

Radiation Versus Immune Checkpoint Inhibitor Associated Pneumonitis: Distinct Radiologic Morphologies
por: Chen, Xuguang, et al.
Publicado: (2021)

Pseudo-progression with osimertinib after definitive chemoradiation in unresectable epidermal growth factor receptor mutation positive of stage III non-small cell lung cancer: A case report
por: Ren, Fei, et al.
Publicado: (2022)

Evaluating Proton Dose and Associated Range Uncertainty Using Daily Cone-Beam CT
por: Li, Heng, et al.
Publicado: (2022)

Time to deterioration of patient-reported outcomes in non-small cell lung cancer: exploring different definitions
por: Walding, Andrew, et al.
Publicado: (2022)

Genomic Analyses for Predictors of Response to Chemoradiation in Stage III Non-Small Cell Lung Cancer
por: Luo, Leo Y., et al.
Publicado: (2020)

Implications of pneumonitis after chemoradiation and durvalumab for locally advanced non-small cell lung cancer
por: Hassanzadeh, Comron, et al.
Publicado: (2020)

A Case Report of an Early Response to Definitive Chemoradiation for Esophageal Carcinoma Cuniculatum
por: Long, David E., et al.
Publicado: (2020)

What is the Definition of Cure in Non-small Cell Lung Cancer?
por: Morgan, Helen, et al.
Publicado: (2021)

Association of lung fluorodeoxyglucose uptake with radiation pneumonitis after concurrent chemoradiation for non-small cell lung cancer
por: Yue, Jinbo, et al.
Publicado: (2017)

Long-term patient-reported distress in locally advanced cervical cancer patients treated with definitive chemoradiation
por: Conway, Jessica L., et al.
Publicado: (2020)

Clinical Outcome in Definitive Concurrent Chemoradiation With Weekly Paclitaxel and Carboplatin for Locally Advanced Esophageal and Junctional Cancer
por: Noronha, Vanita, et al.
Publicado: (2016)

Outcomes and Tolerability of Definitive and Preoperative Chemoradiation in Elderly Patients With Esophageal Cancer: A Retrospective Institutional Review
por: Rahimy, Elham, et al.
Publicado: (2020)

Significance of neutrophil to lymphocyte ratio as a predictor of outcome in head and neck cancer treated with definitive chemoradiation
por: Kaźmierska, Joanna, et al.
Publicado: (2023)

Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab
por: Jazieh, Khalid, et al.
Publicado: (2022)

Pattern of failure and clinical value of local therapy for oligo‐recurrence in locally advanced non‐small cell lung cancer after definitive chemoradiation: Impact of driver mutation status
por: Zhang, Jinmeng, et al.
Publicado: (2022)

Correction to: Time to deterioration of patient-reported outcomes in non-small cell lung cancer: exploring different definitions
por: Walding, Andrew, et al.
Publicado: (2022)

Association of Driver Oncogene Variations With Outcomes in Patients With Locally Advanced Non–Small Cell Lung Cancer Treated With Chemoradiation and Consolidative Durvalumab
por: Liu, Yufei, et al.
Publicado: (2022)

Superior vena cava syndrome in a patient with locally advanced lung cancer with good response to definitive chemoradiation: a case report
por: Hinton, Jason, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qhtr9j7b8os00egka7mloecjf6